Ethereum News Today: 180 Life Sciences Unconfirmed $425M Ethereum Treasury Plan as ETH Surges 114.62% in 90 Days

180 Life Sciences, a Nasdaq-listed company, has reportedly initiated unconfirmed plans to raise $425 million through private financing to establish a significant Ethereum treasury, alongside a potential rebranding to ETHZilla Corporation [1]. These claims, first surfaced by ChainCatcher, suggest the company may pivot toward institutional cryptocurrency adoption by allocating substantial funds to Ethereum (ETH). However, neither 180 Life Sciences nor the purported investors—Harbour Island and Electric Capital—have issued official confirmations [1]. The absence of regulatory filings or on-chain transaction evidence leaves the reports in the realm of speculation, complicating efforts to assess their validity.

The proposed treasury, if realized, could mirror corporate strategies such as MicroStrategy’s Bitcoin accumulation, which historically influenced cryptocurrency valuations through institutional adoption [1]. Ethereum’s recent performance, including a 114.62% gain over 90 days and a market cap of $456.39 billion, underscores growing institutional interest in digital assets [1]. Yet, no discernible market reaction to the unverified 180 Life Sciences news has been observed. As of July 29, 2025, ETH traded at $3,780.89, with a 24-hour trading volume of $34.70 billion, down 2.35% [1]. Analysts caution that speculative narratives around corporate crypto acquisitions often diverge from actual market impacts until verified announcements are made [1].

The lack of official communication from 180 Life Sciences or stakeholders highlights the challenges of interpreting unconfirmed corporate moves in the crypto sector. While historical precedents, such as MicroStrategy’s Bitcoin strategy, have driven measurable price shifts, the absence of confirmed actions here means any potential influence on Ethereum remains theoretical. Coincu research experts note that past corporate crypto initiatives, when verified, have bolstered investor confidence and altered market dynamics. However, without tangible evidence—such as regulatory disclosures or blockchain transaction records—these discussions remain speculative [1].

The proposed rebranding to ETHZilla further complicates the narrative, as it signals a symbolic alignment with Ethereum’s ecosystem. Yet, the company’s current public statements offer no indication of such a shift. This ambiguity raises questions about the feasibility of the project and the credibility of the reported investors’ involvement. Stakeholders, including investors and market participants, appear to be adopting a cautious stance, awaiting concrete validations before assessing the potential implications for Ethereum’s institutional adoption trajectory [1].

Sources:

[1] "Unconfirmed: 180 Life Sciences Plans $425M Ethereum Treasury," CoinMarketCap Community Article (https://coinmarketcap.com/community/articles/6888e3119f4cdb0e82758fab/)